MENU

Why Healthscope Ltd shares are storming higher today

One of the best performers on the market this morning has been the Healthscope Ltd (ASX: HSO) share price.

At the time of writing the private hospital operator’s shares are up approximately 4% to $2.50.

Why are Healthscope’s shares on the rise?

This morning Healthscope revealed that NorthWest Healthcare Properties REIT (NWH) has acquired a 10% interest in the company.

According to the release, NWH acquired the interest at a price of $2.39 per share by way of a derivative with Deutsche Bank.

This is 3 cents per share above the unsolicited and conditional acquisition proposal the company received from the BGH Consortium last month.

Today’s release goes on to explain that: “An acquisition of Healthscope’s underlying hospital related real estate is of interest to NWH and Vital Healthcare Property Trust (Vital) in line with their long term strategy to invest in healthcare real estate assets in the Australasian market. NWH and Vital currently intend to pursue any potential Healthscope real estate acquisition jointly, with scope to introduce other capital partners as appropriate.”

What is NorthWest Healthcare Properties REIT?

NorthWest Healthcare Properties is a Canadian listed real estate investment trust with a focus on high quality healthcare real estate assets.

Its diversified portfolio of 149 income-producing properties and 10.1 million square feet of gross leasable area are found across the world.

According to the AFR, the REIT is expected to tell both Healthscope and the BGH Consortium that it is willing to work with either party to invest in Healthscope’s property portfolio.

What now?

This certainly throws a spanner into the works but could ultimately be a big positive for shareholders that held on during the takeover talks.

It also appears to have given the Ramsay Health Care Limited (ASX: RHC) share price a lift as well today. Its shares are up over 1% in morning trade.

I would suggest investors keep their powder dry and wait for the situation to develop further.

Instead, I think investors ought to be snapping up these top blue chips.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.